JODY GRAY: Open Payments
NPI 1538462197 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 64 payments from 14 companies in 2025. Trend: 2023 $265 · 2024 $1,079 · 2025 $1,193
Food & beverage: $1,193
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $242 |
| ABBVIE INC. | 10 | $227 |
| PFIZER INC. | 18 | $213 |
| Novo Nordisk Inc | 9 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Exact Sciences Corporation | 3 | $55 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $24 |
Products named: UBRELVY, NURTEC ODT, FARXIGA, Kerendia, QULIPTA, Ozempic, JARDIANCE, Wegovy.
Industry payments across WA — which companies pay providers there.
